| __timestamp | Bausch Health Companies Inc. | Genmab A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 6008900000 | 850385000 |
| Thursday, January 1, 2015 | 7853800000 | 1133041000 |
| Friday, January 1, 2016 | 7063000000 | 1816122000 |
| Sunday, January 1, 2017 | 6176000000 | 2365436000 |
| Monday, January 1, 2018 | 6029000000 | 3025137000 |
| Tuesday, January 1, 2019 | 6251000000 | 5366000000 |
| Wednesday, January 1, 2020 | 5778000000 | 10111000000 |
| Friday, January 1, 2021 | 6040000000 | 8482000000 |
| Saturday, January 1, 2022 | 5760000000 | 14595000000 |
| Sunday, January 1, 2023 | 6198000000 | 16248000000 |
| Monday, January 1, 2024 | 20541000000 |
Unleashing insights
In the ever-evolving landscape of the pharmaceutical industry, understanding financial trends is crucial. Over the past decade, Genmab A/S and Bausch Health Companies Inc. have showcased contrasting trajectories in their gross profits. From 2014 to 2023, Genmab A/S experienced a remarkable growth, with its gross profit surging by over 1,800%, peaking at approximately $16.25 billion in 2023. This growth reflects Genmab's strategic advancements in biotechnology and innovative therapies.
Conversely, Bausch Health Companies Inc. displayed a more stable yet fluctuating pattern, with gross profits hovering around the $6 billion mark. Despite a peak in 2015, Bausch's profits have seen a slight decline, indicating potential challenges in market adaptation. This comparison not only highlights the dynamic nature of the pharmaceutical sector but also underscores the importance of strategic innovation and market responsiveness.
Gross Profit Trends Compared: Regeneron Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Genmab A/S and Exelixis, Inc.: A Detailed Gross Profit Analysis
Genmab A/S vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Genmab A/S and Ligand Pharmaceuticals Incorporated Trends
SG&A Efficiency Analysis: Comparing Genmab A/S and Bausch Health Companies Inc.
Walgreens Boots Alliance, Inc. and Bausch Health Companies Inc.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Jazz Pharmaceuticals plc and Bausch Health Companies Inc.
Key Insights on Gross Profit: Halozyme Therapeutics, Inc. vs Bausch Health Companies Inc.
Gross Profit Trends Compared: Lantheus Holdings, Inc. vs Bausch Health Companies Inc.
Gross Profit Trends Compared: Alkermes plc vs Bausch Health Companies Inc.
Gross Profit Comparison: Bausch Health Companies Inc. and Supernus Pharmaceuticals, Inc. Trends
Bausch Health Companies Inc. and Evotec SE: A Detailed Gross Profit Analysis